STAT3 and hepatocellular carcinoma: However, in many cases, frame deletionmutations in Gp 130 and point mutations in Jak2 (Morgan and Gilliland, 2008) promote the ligand-independentactivation of STAT-3 found in hepatocellular carcinomas (Rebouissou et al., 2008).